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INTRODUCTION
kIt	is	well	known	that	the	Internet	allows	rapid	circu-
lation	of	new	drugs	and	novel	methods	of	use.	Studies	
have	shown	that	users	modify	drug	use	based	on	in-
formation	obtained	from	the	internet.	The	information	
from	innovative	users	can	then	be	quickly	distributed	
via	e-mail,	instant	messaging	and	cell	phones.
In	the	present	paper	we	present	the	current	trends	
of	drug	abuse	in	the	US.	Some	of	them	are	expected	
to	arrive	in	Europe	and	it	is	necessary	to	be	aware	of	
them	in	order	to	recognize	them,	to	estimate	their	pos-
sible	effects	and	to	treat	abusers.
Α) Abuse of prescription drugs
The	abuse	of	prescription	drugs	is	becoming	more	and	
more	popular	due	to	the	easy	access	to	them.	Actually,	
cannabis	is	the	only	drug	abused	more	frequently	than	
prescription	drugs	and	although	the	rate	of	illicit	drug	
use	 among	 adolescents	 is	 declining,	 the	 rate	 of	 pre-
scription	drug	abuse	is	increasing.
The	most	common	prescription	drugs	abused	in	the	
US	are	 the	opioid	analgesics	and	dextromethorphan,	
although	 another	 very	 popular	 trend	 is	 the	 abuse	 of	
mixtures	of	prescription	drugs	which	makes	diagnosis	
and	treatment	very	difficult.
1) Opioid Analgesics
Opioid	 analgesics	 are	 among	 the	 most	 commonly	
abused	 prescription	 drugs.	 In	 the	 US	 a	 prescription	
drug	containing	oxycodone1	together	with	acetamino-
phen	has	become	very	popular	and	 its	abuse	has	 in-
creased	by	almost	40%	between	2002-2005.
Opioid	analgesics	are	usually	ingested.	Neverthe-
less,	crushed	 tables	can	be	 injected	 intravenously	or	
can	be	intranasally	insufflated.	
Another	substance	becoming	more	and	more	pop-
ular	is	fentanyl2.	Fentanyl	has	50-100x	the	potency	of	
morphine	and	the	patches	contain	significant	amounts	
of	it	even	after	a	typical	3	day	application.	Fentanyl	is	
usually	prescribed	as	a	strong	pain	reliever	in	cancer	
patients.
Fentanyl	is	usually	abused	by:
-	 Placing	multiple	 patches	 on	 skin	 for	 dermal	 ab-
sorption
-	 Ingesting	and	chewing	the	patch	to	disrupt	the	de-
pot	reservoir
-	 Boiling	patches	to	make	fentanyl	tea
-	 Contaminating	 heroin.	 The	 produced	 mix	 has	 a	
higher	 potency	 than	 heroin	 alone	 and	 can	 be	 re-
sponsible	 for	 periodic	 death	 epidemics	 in	 opioid	
users.
Clinical Effects
The	abuse	of	opioid	analgesics	has	the	following	clin-
ical	manifestations:
a)	 Opioid	 Toxidrome	 (Toxic	 Syndrome)	 which	 in-
cludes	meiosis,	mental	 status	 and	 respiratory	de-
pression	and	decreased	bowel	motility.	
b)	 Histamine	release	from	anaphylactoid	reaction.
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c)	 Acute	lung	injury.
d)	 Development	of	tolerance	to	euphoria	and	mental	
status	depression	but	not	to	respiratory	depressant	
effects.
2) Dextromethorphan
Dextromethorphan	 (DXM	 or	 DM)	 is	 an	 antitussive	
(cough	 suppressant)	 drug	 found	 in	 many	 over-the-
counter	cold	and	cough	medicines.	Pure	dextrometho-
rphan	occurs	as	a	powder	made	up	of	white	crystals,	
but	it	is	generally	administered	via	syrups,	tablets,	or	
lozenges	manufactured	under	several	different	brand	
names	and	generic	labels.
When	taken	at	doses	higher	than	are	medically	rec-
ommended,	 dextromethorphan	 acts	 as	 a	 dissociative	
hallucinogenic	drug.	 It	 is	 classified	neurochemically 
as	an	NMDA	receptor	antagonist.	Its	effects	are	simi-
lar	to	those	of	the	controlled	substances	ketamine	and	
phencyclidine	(PCP)	and	therefore	it	has	a	significant	
potential	for	abuse.
Dextromethorphan3	 is	 often	 abused	 by	 adoles-
cents.	Its	«street	names»	are	Robo,	Dex,	DXM,	Triple	
C	 and	 Skittles.	 It	 is	 typically	 ingested	 although	 an-
other	 popular	 practice	 is	 the	 so	 called	«Freebasing»	
which	 is	 a	 lemon	extraction	method	 leading	 to	pure	
dextromethorphan	without	additives.
Clinical effects
The	 abuse	 of	 dextromethorphan	 has	 the	 following	
clinical	manifestations:
a)	 Euphoria,	 dysphoria,	 dissociative	 phenomenon,	
somnolence,	hallucinations,	ataxia,	slurred	speech,	
tachycardia,	hypertension,	diaphoresis,	and	rotary	
nystagmus.
b)	 Patients	taking	cough	and	cold	preparations	are	at	
risk	for	poisoning	from	other	mediciations	such	as	
acetaminophen,	 pseudoephedrine,	 antihistamines	
and	bromide.
B) Novel practices of abuse-Pharming
The	 term	 «Pharming»	 is	 used	 to	 describe	 a	 special	
prescription	 drug	 abuse	 setting4.	 Adolescents	 take	
medications	from	their	homes	and	bring	them	to	par-
ties	where	they	are	mixed	together	in	bowls.	The	med-
ications	are	passed	around	and	ingested	and	this	mul-
tidrug	ingestion	of	what	may	be	unknown	substances	
can	make	diagnosis	and	treatment	more	difficult.
C) Cheese
Cheese	 gained	 national	 attention	 in	 the	US	 in	 2005	
when	 it	 was	 linked	 to	 the	 deaths	 of	 several	 Dallas	
teenagers.	It	targets	adolescents	and	is	called	«starter	
heroin».	It	is	a	mixture	of	heroin	with	cold	and	cough	
preparations.	In	this	mixture	the	heroin	content	is	typi-
cally	lower	than	in	other	types	of	heroin.	This	is	usu-
ally	insufflated	and	not	injected.
Clinical findings
Cheese	has	the	following	clinical	manifestations:
a)	 Opioid	toxidrome
b)	 Other	findings,	related	to	the	nature	of	the	coinges-
tants.	 For	 example	 diphenhydramine	 causes	 the	
anticholinergic	toxidrome	(blurred	vision,	choreo-
athetosis,	 coma,	 decreased	 bowel	 sounds,	 deliri-
um,	dry	skin,	fever,	flushing,	hallucinations,	ileus,	
memory	 loss,	 mydriasis,	 myoclonus,	 psychosis,	
seizures,	and	urinary	retention).
D) Phenylethylamines
They	are	amphetamine	derivatives	either	naturally	oc-
curring	(mescaline)	or	synthetic,	known	as	«designer	
drugs».	 There	 are	 hundreds	 of	 derivatives,	 but	 the	
most	common	examples	are:
-	 methylenedioxymethamphetamine	 (MDMA-Ec-
stacy)
-	 4-bromo-2,5-dimethoxyphenethylamine	(2C-B)
-	 2,5-dimethoxy-4-ethylthiophenylethylamine	 (2C-
T-2)
-	 1-(8-bromobenzo[1,2-b;4,5-b’]difuran-4-yl)	 -2-
aminopropane	(Bromofly,	Bromodragonfly).
All	of	these	substances	have	an	amphetamine-like	
structure	with	substitutions	that	enhance	their	ability	
to	affect	serotonin	release.	Many	of	these	compounds	
are	also	structurally	similar	 to	serotonin	and	bind	 to	
the	SHT
2
	receptor.
The	phenylethylamines	are	widely	abused	in	Eu-
rope	and	are	included	in	the	list	of	abused	substances	
issued	by	the	European	Monitoring	Centre	for	Drugs	
and	Drug	Addiction.
Clinical Effects
The	 abuse	 of	 phenylethylamines	 has	 the	 following	
clinical	manifestations:
a)	 Amphetamine-like	 effects	 (headache,	 hyperten-
sion,	tachycardia,	agitation,	seizures).
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b)	 Serotoninergic	 effects	 (euphoria,	 hallucination,	
nausea	and	vomiting).
c)	 Deaths	reported	often	from	hyperthermia.	
E) Cathinone and Metcathinone (Cat, Khat, Jeff)
Cathinone	(benzylketoamphetamine)	is	naturally	con-
tained	in	leaves	of	Catha	edulis, a	plant	used	in	East	
Africa	and	the	Arabic	peninsula,	particularly	in	social	
ceremonies	such	as	weddings.	It	is	also	known	as	quat	
and	gat	and	is	reported	to	be	an	increasingly	common	
drug	 intercepted	by	US	Customs	and	 the	DEA.	It	 is	
imported	as	 the	fresh	plant,	gathered	 in	bundles	and	
must	be	consumed	within	a	few	days	of	harvest.	It	is	
either	chewed	or	brewed	into	tea.
According	 to	 previous	 work	 of	 our	 laboratory5,	
cathinone	 and	 metcathinone	 have	 already	 appeared	
in	the	European	and	Hellenic	market	and	are	gaining	
great	popularity.
Clinical effects
The	 abuse	 of	 cathinone	 has	 the	 following	 clinical	
manifestations:
a)	 Increased	 alertness,	 euphoria,	 insomnia,	 anxiety	
and	hyperactivity.
b)	 Increased	consumption	linked	to	psychosis.
Metcathinone	is	a	similar	synthetic	amphetamine,	
synthesized	and	used	in	Russia	since	the	1970s.	It	is	
the	main	drug	of	abuse	in	Russia,	exceeding	cocaine.	
It	is	called	Cat	and	Jeff6.
Clinical effects
The	abuse	of	metcathinone	has	clinical	manifestations	
similar	to	methamphetamine:
Psychomotor	agitation,	anorexia,	hallucinations.
F) Ketamine
Ketamine	 is	 known	 as	 «special	 K,»	 «K»,	 «Vitamin	
K»,	«Fort	Dodge».	 It	 is	a	dissociate	anesthetic	mar-
keted	in	1970	as	a	phencyclidine	(PCP)	alternative.	It	
was	first	used	in	veterinary	medicine	and	until	today	
ketamine	from	the	street	is	often	a	diverted	veterinary	
preparation.
It	is	very	popular	in	clubs	for	its	out	of	body	expe-
rience,	its	low	price	and	its	short	duration	of	action7.
The	 solvent	 is	 usually	 evaporated	 leaving	 white	
crystalline	material	which	 is	 used	 by	 insufflation	 or	
ingestion.	Low	doses	 (Insufflation	30-75	mg,	 Inges-
tion	75-300	mg)	lead	to	sedation	while	higher	doses	
(Insufflation	100-250	mg,	Ingestion	300-450	mg)	re-
sult	in	more	severe	CNS	toxicity.
Tablets	of	ketamine	often	contain	other	substances	
such	as	cocaine	 (CK=cocaine	+	ketamine),	caffeine,	
MDMA,	ephedrine,	methamphetamine	and	heroin.
According	 to	 previous	 work	 of	 our	 laboratory5,	
ketamine	has	 already	 appeared	 in	 the	European	 and	
Hellenic	market.
Clinical Effects
The	 clinical	 effects	 occur	 in	minutes	 and	 last	 30-90	
minutes.	 The	 presentation	 varies,	 according	 to	 the	
dose,	 the	 route	 of	 administration,	 the	 contaminants	
and	the	tolerance.	Its	effects	include:
a)	 Mild	sympathomimetic	effects	-	hypertension	and	
tachycardia.
b)	 Variable	CNS	effects.
-	 Maybe	be	calm,	sedated	or	comatose.
-	 Out	of	body	sensations.
-	 «K-hole».	 Adverse	 reaction	 which	 includes	
dysphoria,	severe	hallucination,	vomiting,	and	
catatonia,	and	lasts	minutes	to	hours.
-	 Maybe	have	psychomotor	agitation.
-	 Psychosis	can	occur.
-	 Severe	emergence	reactions.
-	 Classically	 associated	with	 rotary	 nystagmus,	
also	ataxia	and	gait	disturbances.
G) Salvia divinorum (Divine Mint)
It	is	a	herb	classified	as	a	member	of	the	Mint	family.	
It	is	also	called	«La	Pastora»	«Yerba	Maria»,	«Divin-
er’s	Mint»,	 «Diviner’s	Sage».	 It	 is	 used	 for	medici-
nal	and	spiritual	purposes	by	the	Mazatec	Indians	in	
Mexico	and	it	is	available	in	a	variety	of	stores,	«head	
shops»	and	online.	The	Internet	has	played	a	large	role	
in	the	expansion	of	this	substance	since	it	is	advertised	
as	 a	hallucinogen	 that	 cannot	be	detected	on	a	drug	
screen8.
The	plant	has	many	different	compounds.	The	ac-
tive	 ingredient	 is	 probably	 salvinorin	A,	which	 is	 a	
hallucinogen.	 The	 plant	 can	 be	 smoked	 or	 chewed.	
Smoking	 has	 an	 immediate	 onset	 of	 hallucinations,	
but	a	shorter	duration.	Chewing	has	a	slower	onset	of	
hallucinations	but	duration	is	longer	than	with	smok-
ing.
Clinical Effects
The	abuse	of	salvia divinorum	has	the	following	clini-
cal	manifestations:
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a)	 Euphoria,	out	of	body	experiences,	hallucinations,	
uncontrolled	laughter,	synesthesia
b)	 One	death	associated	with	use	though	role	of	Sal-
via	is	controversial.
The	duration	of	action	is	short,	lasting	between	30	
minutes	and	2	hours.
The	above	presented	information	reflects	the	cur-
rent	trends	in	drug	abuse	in	the	US.	These	trends	in-
volve	 either	 new	 substances	 being	 abused	 or	 novel	
practices	of	abuse	of	already	known	substances.
As	mentioned	before,	some	of	these	trends	are	ex-
pected	 to	arrive	 in	Europe,	as	has	already	happened	
with	 the	phenylethylamines,	ketamine	and	Khat.	On	
the	other	hand,	other	trends	will	never	reach	our	con-
tinent.
Clinical	toxicologists	must	be	aware	of	these	trends	
in	order	to	be	able	to	recognize	them	and	treat	them	as	
effectively	as	possible.
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ΠΕΡΙΛΗΨΗ:	Στην	εργασία	αυτή	παρουσιάζονται	οι	σημερινές	τάσεις	στην	κατάχρηση	ουσιών	που	επικρατούν	στις	ΗΠΑ.	
Κάποιες	από	αυτές	αναμένεται	να	εμφανιστούν	και	στην	Ευρώπη.	Η	γνώση	τους	θα	μας	επιτρέψει	να	τις	αναγνωρίσουμε	
εγκαίρως	και	να	αξιολογήσουμε	την	τοξική	τους	δράση.	Παρουσιάζονται	οι	διάφορες	χημικές	κατηγορίες,	ο	τρόπος	κατά-
χρησής	τους	και	τα	κλινικά	συμπτώματά	τους	καθώς	επίσης	και	νέες	πρακτικές	κατάχρησης	ουσιών.
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Οι νέες τάσεις στις ΗΠΑ στην κατάχρηση ουσιών.
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